Monurol and Lactulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Monurol (fosfomycin tromethamine) and Lactulose (lactulose). Common drug interactions include fungal infection among females and colon cancer metastatic among males.

The phase IV clinical study analyzes what interactions people have when they take Monurol and Lactulose. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Monurol?

Monurol has active ingredients of fosfomycin tromethamine. eHealthMe is studying from 710 Monurol users. Check the latest studies of Monurol.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.



On Jul, 07, 2026

14 people who take Monurol and Lactulose together, and have interactions are studied.

Monurol and Lactulose drug interactions.

What are the common drug interactions of Monurol and Lactulose, by gender? *:

female:

  1. Fungal infection
  2. Chronic kidney disease
  3. Fall
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Inappropriate antidiuretic hormone secretion
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Nephropathy (damage to or disease of a kidney)
  9. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  10. Rash pruritic (redness with itching)

male:

  1. Colon cancer metastatic (cancer of colon spreads to other part of body)
  2. Urinary tract infection
  3. Hospitalisation
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Hypotension (abnormally low blood pressure)
  6. Infection
  7. Lip swelling
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Plasmacytoma (neoplasm of plasma cells (usually in bone marrow))
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Monurol and Lactulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Fungal infection
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Nephropathy (damage to or disease of a kidney)
  5. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  6. Rash pruritic (redness with itching)
  7. Renal failure (kidney dysfunction)
  8. Renal impairment (severely reduced kidney function)
  9. Chronic kidney disease

60+:

  1. Colon cancer metastatic (cancer of colon spreads to other part of body)
  2. Chronic kidney disease
  3. Fall
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Inappropriate antidiuretic hormone secretion
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Plasmacytoma (neoplasm of plasma cells (usually in bone marrow))
  9. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Infection: 6 people, 42.86%
  2. Multiple Myeloma (cancer of the plasma cells): 5 people, 35.71%
  3. Pain: 5 people, 35.71%
  4. Cough: 5 people, 35.71%
  5. Neuropathy Peripheral (surface nerve damage): 4 people, 28.57%
  6. Neuralgia (pain in one or more nerves): 4 people, 28.57%
  7. Sleep Disorder: 4 people, 28.57%
  8. Erection Problems: 4 people, 28.57%
  9. Sinus Disorder (disease of sinus): 4 people, 28.57%
  10. Nausea (feeling of having an urge to vomit): 4 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Monurol and Lactulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Monurol and Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Monurol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Monurol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fosfomycin tromethamine and lactulose (the active ingredients of Monurol and Lactulose, respectively), and Monurol and Lactulose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: